METHOD FOR PREPARING DRUG COMPOSITION BASED ON INCREASING ACTIVE AGENT AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES Russian patent published in 2012 - IPC A61K9/16 A61K38/28 A61K38/27 A61K47/22 A61K47/30 A61J3/00 

Abstract RU 2443414 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to a crystalline microparticle for deliverying active agents which contains diketopiperazine and polysorbate 80. The invention also refers to a method for making said microparticle. The method involves the stages for preparing a diketopiperazine solution with limited solubility and low pH value, adding polysorbate 80 to the solution and precipitating diketopiperazine microparticles at the stages of adding acid to the solution. The invention also refers to a method of coating the pre-formed said microparticle. The method involves producing a suspension containing the pre-formed crystalline microparticle, the active agent and the solvent, changing the suspension properties for controlling power interaction between the specified active agent and pre-formed crystalline microparticle and absorbing the active agent on the microparticle surface for the purpose of coating. The stage of changing the properties and the stages of absorbing proceed without removing the solvent from the suspension.

EFFECT: invention provides making stable particles whereto the active agent has higher affinity than to the solution wherein is found.

15 cl, 8 dwg, 4 tbl, 7 ex

Similar patents RU2443414C2

Title Year Author Number
METHOD OF OBTAINING MEDICAL COMPOSITION, BASED ON INCREASE OF CRYSTAL MICRO PARTICLES SURFACE AFFINITY TO ACTIVE AGENTS 2006
  • Oberg Kit A.
RU2394550C2
METHOD FOR PREPARING DRUG BASED ON HIGHER AFFINITY OF ACTIVE AGENTS TO CRYSTALLINE MICROPARTICLE SURFACES 2006
  • Khouknson Mark
  • Oberg Kit A.
RU2390325C2
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE (GLP-1) 2007
  • Grin Stefani
  • Brandt Dehvid
  • Gel'Ber Kokhava
  • King Mark
  • Chizam Vehjman Vehndell
  • Oberg Kit
  • Leone-Behj Andrea
  • Khoukenson Mark Dzh.
  • Fejris Mehri
RU2409349C2
PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) 2007
  • Grin Stefani
  • Brandt Dehvid
  • Gel'Ber Kokhava
  • King Mark
  • Chizam Vehjman Vehndell
  • Oberg Kit
  • Leone-Behj Andrea
  • Khoukenson Mark Dzh.
  • Fejris Mehri
RU2542500C2
METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT 2007
  • Uilson Brajan R.
  • Grant Marshall
RU2403059C2
DIKETOPIPERAZINE MICROPARTICLES WITH PARTICULAR SPECIFIC SURFACE AREAS 2010
  • Grant Marshall L.
  • Stouehll Grejson U.
  • Menkin Pol
RU2509555C2
DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS 2010
  • Kraft Kelli S.
  • Somervill Karla
RU2490026C1
ACTIVE SUBSTANCE DELIVERY 2008
  • Boumen Robert A.
  • Richardson Piter
  • Kostello Donal'D
  • Leone-Behj Andrea
RU2467741C2
METHOD FOR PREVENTING GLP-1 SIDE EFFECTS 2008
  • Richardson Piter
  • Boumen Robert A.
  • Kostello Donal'D
RU2474415C2
METHOD FOR PRODUCTION OF MICROPARTICLES OF COMPOUND 2010
  • Gandhi Sanket
  • Moraleda Karen
  • Jachowicz Jadwiga
  • Zupon Michael
RU2673525C2

RU 2 443 414 C2

Authors

Oberg Kit A.

Dates

2012-02-27Published

2010-03-16Filed